Bowhead Specialty (NYSE:BOW - Get Free Report) announced its earnings results on Tuesday. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.51 by $0.03, Zacks reports. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%. The company had revenue of $171.77 million for the quarter, compared to analyst estimates of $278.64 million.
Bowhead Specialty Price Performance
BOW stock opened at $34.19 on Tuesday. The company has a market capitalization of $1.13 billion, a P/E ratio of 18.47, a price-to-earnings-growth ratio of 1.01 and a beta of -0.07. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.49 and a current ratio of 0.49. Bowhead Specialty has a 52-week low of $21.21 and a 52-week high of $35.24. The business has a 50-day simple moving average of $33.86 and a two-hundred day simple moving average of $28.58.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on BOW. Keefe, Bruyette & Woods lifted their target price on Bowhead Specialty from $34.00 to $36.00 and gave the stock an "outperform" rating in a report on Wednesday, July 8th. Morgan Stanley raised their price objective on shares of Bowhead Specialty from $30.00 to $34.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft lowered shares of Bowhead Specialty from a "buy" rating to a "hold" rating and set a $34.00 price objective for the company. in a research note on Monday, August 3rd. Citizens Jmp downgraded shares of Bowhead Specialty from an "outperform" rating to a "market perform" rating in a research report on Thursday, September 10th. Finally, Piper Sandler cut shares of Bowhead Specialty from an "overweight" rating to a "hold" rating and set a $34.00 price target for the company. in a report on Monday, August 3rd. One research analyst has rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $33.50.
Get Our Latest Stock Report on Bowhead Specialty
About Bowhead Specialty
(
Get Free Report)
Bowhead Specialty NYSE: BOW is a specialty insurance holding company that provides coverage for complex and hard-to-place risks. Through its insurance subsidiaries, the company primarily underwrites specialty products for businesses and organizations across the United States.
Its offerings include casualty insurance, professional liability coverage, healthcare-related liability products and other specialty lines. Bowhead distributes its products primarily through wholesale insurance brokers, serving customers whose needs may not be met by standard commercial insurance carriers.
The company was established in 2020 and became a publicly traded company in 2024.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.